Skip to main content

Table 1 Patient data collection at three assessment moments during the trial

From: Nurse-led telecoaching of people with type 2 diabetes in primary care: rationale, design and baseline data of a randomized controlled trial

Patient data

Method of collection

Baseline (T0)

T0 + 6 months

T0 + 18 months

Gender

Sickness funds database

x

  

Age

Sickness funds database

x

  

Education

Self-reporting

x

  

Occupation

Self-reporting

x

  

Diabetes 2 since

Self-reporting

x

  

Comorbidities:

Self-reporting

x

 

x

Cardiovascular: CHD; heart failure; atherosclerosis; past MI; stroke; TIA

    

Respiratory: COPD; asthma

    

Other: hypoglycemia; hypertension; dyslipidemia; Kidney disease; neuropathy; depression

    

Family history of type 2 diabetes and cardiovascular disease

Self-reporting

x

  

Blood pressure

Home visit test

x

x

x

Height

Home visit test

x

  

Weight

Home visit test

x

x

x

BMI

Calculated

x

x

x

Waist circumference

Home visit test

x

x

x

Prescribed medications

Sickness funds database + self- reporting

x

x

x

Smoking

Self-reporting + CO test

x

x

x

Lifestyle: physical activity; alcohol consumption; healthy eating

Self-reporting

x

x

x

Diabetes risk factor knowledge test

Self-reporting

x

x

x

EQ-5D

Self-reporting

x

x

x

PAID

Self-reporting

x

x

x

DTSQ – status version

Self-reporting

x

x

x

HbA1c

Pathology lab

x

x

x

Lipid profile: TC; HDL; LDL; TG

Pathology lab

x

x

x

Satisfaction about the COACH program (Intervention group)

Self-reporting

 

x

 

Costs

Sickness funds database; time& material sheets; contracts

x

x

x

  1. Abbreviations: CHD Coronary Heart disease, MI Myocardial Infarction, TIA Transient Ischemic Attack, COPD Chronic Obstructive Pulmonary Disease, EQ-5D EuroQol 5 dimension health status questionnaire, PAID Problem Areas in Diabetes Questionnaire, DTSQ Diabetes Treatment Satisfaction Questionnaire; HbA1c glycohemoglobin, TC total cholesterol, HDL high-density lipoprotein, LDL law-density lipoprotein, TG triglycerides.